A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

Rodger D. MacArthur, Richard M. Novak, Grace Peng, Li Chen, Ying Xiang, Katherine Huppler Hullsiek, Michael J. Kozal, Mary van den Berg-Wolf, Christopher Henely, Barry Schmetter,

The Lancet · 2006 · 139 citations · 26 references

Concepts

References

26